Literature DB >> 24666705

Association between viral load of varicella zoster virus in cerebrospinal fluid and the clinical course of central nervous system infection.

Amihai Rottenstreich1, Zipi Kra Oz2, Ilana Oren3.   

Abstract

Varicella zoster virus (VZV) like other alphaherpes viruses stays latent after its primary infection. During its reactivation, it can infect the central nervous system (CNS) causing a variety of clinical presentations. Using polymerase chain reaction (PCR) for detection of VZV DNA in cerebrospinal fluid (CSF), it is now recognized in some series as the most common causative agent of viral CNS infection. We aimed to investigate in our study the correlation between VZV viral load in the CSF and the clinical course of its infection, using quantitative real-time PCR. For this purpose, we examined 56 specimens of consecutive patients with positive CSF for VZV DNA in a qualitative test, with a clinical picture of meningitis or encephalitis collected over 10years in Rambam medical center. We found a significant correlation between VZV viral load and the severity and duration of neurological disease. We believe that using quantitative measurement of VZV DNA in the CSF, could serve as a prognostic marker which would influence treatment decisions.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Central Nervous System; Quantitative; Real-time PCR; Varicella Zoster Virus

Mesh:

Substances:

Year:  2014        PMID: 24666705     DOI: 10.1016/j.diagmicrobio.2014.02.015

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  7 in total

1.  Development and Validation of a Laboratory-Developed Multiplex Real-Time PCR Assay on the BD Max System for Detection of Herpes Simplex Virus and Varicella-Zoster Virus DNA in Various Clinical Specimens.

Authors:  Sylvie Pillet; Paul O Verhoeven; Amélie Epercieux; Thomas Bourlet; Bruno Pozzetto
Journal:  J Clin Microbiol       Date:  2015-04-15       Impact factor: 5.948

2.  Complications of Varicella Zoster Infection of the Central Nervous System.

Authors:  Anusha S Thomas; Jose A Perez
Journal:  Methodist Debakey Cardiovasc J       Date:  2017 Apr-Jun

3.  Incidence of varicella zoster virus infections of the central nervous system in the elderly: a large tertiary hospital-based series (2007-2014).

Authors:  M Arruti; L D Piñeiro; Y Salicio; G Cilla; M A Goenaga; A López de Munain
Journal:  J Neurovirol       Date:  2017-02-21       Impact factor: 3.739

4.  CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)-Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).

Authors:  M Schmidt-Hieber; G Silling; E Schalk; W Heinz; J Panse; O Penack; M Christopeit; D Buchheidt; U Meyding-Lamadé; S Hähnel; H H Wolf; M Ruhnke; S Schwartz; G Maschmeyer
Journal:  Ann Oncol       Date:  2016-04-06       Impact factor: 32.976

5.  Metagenomic Next-Generation Sequencing vs. Traditional Microbiological Tests for Diagnosing Varicella-Zoster Virus Central Nervous System Infection.

Authors:  Yunqi Zhu; Miaomiao Xu; Chengyuan Ding; Zhihang Peng; Weixiao Wang; Binghu Sun; Jian Cheng; Chen Chen; Wei Chen; Hongxia Wei; Zhiliang Hu
Journal:  Front Public Health       Date:  2022-01-21

6.  Implementation and Evaluation of a Fully Automated Multiplex Real-Time PCR Assay on the BD Max Platform to Detect and Differentiate Herpesviridae from Cerebrospinal Fluids.

Authors:  Thomas Köller; Daniel Kurze; Mirjam Lange; Martin Scherdin; Andreas Podbielski; Philipp Warnke
Journal:  PLoS One       Date:  2016-04-19       Impact factor: 3.240

7.  Neurological complications of varicella zoster virus reactivation: Prognosis, diagnosis, and treatment of 72 patients with positive PCR in the cerebrospinal fluid.

Authors:  Tiphaine Lenfant; Anne-Sophie L'Honneur; Brigitte Ranque; Benoit Pilmis; Caroline Charlier; Mathieu Zuber; Jacques Pouchot; Flore Rozenberg; Adrien Michon
Journal:  Brain Behav       Date:  2022-01-18       Impact factor: 2.708

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.